UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility

Journal of drug targeting, 2010-12, Vol.18 (10), p.704-731

2010

Volltextzugriff (PDF)

Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

European journal of pharmaceutical sciences, 2012-02, Vol.45 (3), p.336-343

2012

Volltextzugriff (PDF)

Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility

Chemical communications (Cambridge, England), 2014-01, Vol.50 (14), p.1688-1690

2014

Volltextzugriff (PDF)

Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats

European journal of pharmaceutics and biopharmaceutics, 2016-04, Vol.101, p.9-14

2016

Volltextzugriff (PDF)

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations

Journal of pharmaceutical sciences, 2012-09, Vol.101 (9), p.3360-3380

2012

Volltextzugriff (PDF)

Increasing the proportional content of surfactant (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs

Pharmaceutical research, 2007-04, Vol.24 (4), p.748-757

2007

Volltextzugriff (PDF)

Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

Pharmaceutical research, 2012-06, Vol.29 (6), p.1485-1494

2012

Volltextzugriff (PDF)

Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to Dogs

Journal of pharmaceutical sciences, 2008-02, Vol.97 (2), p.995-1012

2008

Volltextzugriff (PDF)

MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic

Future oncology (London, England), 2021-04, Vol.17 (12), p.1449-1458

2021

Volltextzugriff (PDF)

Danazol for pelvic pain associated with endometriosis

Cochrane database of systematic reviews, 2007-10 (4), p.CD000068

2007

Volltextzugriff (PDF)

Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets

International journal of pharmaceutics, 2020-03, Vol.577, p.119026, Article 119026

2020

Volltextzugriff (PDF)

Solution or suspension – Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug

European journal of pharmaceutics and biopharmaceutics, 2017-08, Vol.117, p.308-314

2017

Volltextzugriff (PDF)

Formulation of a Danazol Cocrystal with Controlled Supersaturation Plays an Essential Role in Improving Bioavailability

Molecular pharmaceutics, 2013-08, Vol.10 (8), p.3112-3127

2013

Volltextzugriff (PDF)

Application of different methods to predict the lipophilicity parameter of danazol

Farmacja Polska, 2021-12, Vol.77 (10), p.601-607

2021

Volltextzugriff (PDF)

Multicenter Phase 2 Study of Combination Therapy with Ruxolitinib and Danazol in Patients with Myelofibrosis

Leukemia research, 2017-09, Vol.60, p.31-35

2017

Volltextzugriff (PDF)

Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems

European journal of pharmaceutics and biopharmaceutics, 2015-08, Vol.94, p.493-500

2015

Volltextzugriff (PDF)

Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry

British journal of haematology, 2020-06, Vol.189 (5), p.976-981

2020

Volltextzugriff (PDF)

Gonadotropin-releasing hormone analogues for endometriosis

Cochrane database of systematic reviews, 2023-06, Vol.6 (6), p.CD014788

2023

Volltextzugriff (PDF)

Danazol for heavy menstrual bleeding

Cochrane database of systematic reviews, 2007-07 (3), p.CD001017

2007

Volltextzugriff (PDF)

An in Vitro Digestion Test That Reflects Rat Intestinal Conditions To Probe the Importance of Formulation Digestion vs First Pass Metabolism in Danazol Bioavailability from Lipid Based Formulations

Molecular pharmaceutics, 2014-11, Vol.11 (11), p.4069-4083

2014

Volltextzugriff (PDF)

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels

The AAPS journal, 2014-11, Vol.16 (6), p.1344-1357

2014

Volltextzugriff (PDF)

Microbial transformation of danazol with Cunninghamella blakesleeana and anti-cancer activity of danazol and its transformed products

Steroids, 2016-01, Vol.105, p.121-127

2016

Volltextzugriff (PDF)

Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity

Drug metabolism and disposition, 2012-05, Vol.40 (5), p.943-951

2012

Volltextzugriff (PDF)

Electro-Oxidative C-N Bond Formation through Azolation of Indole Derivatives: An Access to 3-Substituent-2-(Azol-1-yl)indoles

Journal of organic chemistry, 2021-11, Vol.86 (22), p.16059-16067

2021

Volltextzugriff (PDF)

Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis

Obstetrics and gynecology (New York. 1953), 2024-01, Vol.143 (1), p.53

2024

Volltextzugriff (PDF)

1 – 25 von 2.632

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.109)
Mit Volltextzugriff
(1.497)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.160)
Female
(1.907)
Science & Technology
(1.696)
Life Sciences & Biomedicine
(1.673)
Danazol - Therapeutic Use
(1.577)
Adult
(1.088)
Biological And Medical Sciences
(757)
Medical Sciences
(737)
Danazol
(692)
Endometriosis - Drug Therapy
(592)
Male
(590)
Obstetrics & Gynecology
(567)
Middle Aged
(516)
Pharmacology. Drug Treatments
(433)
Pregnadienes - Therapeutic Use
(421)
Danazol - Adverse Effects
(413)
Danazol - Administration & Dosage
(390)
Danazol - Pharmacology
(387)
Estrogen Antagonists - Therapeutic Use
(319)
General & Internal Medicine
(268)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility

Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility

Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations

Increasing the proportional content of surfactant (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs

Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to Dogs

MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic

Danazol for pelvic pain associated with endometriosis

Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets

Solution or suspension – Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug

Formulation of a Danazol Cocrystal with Controlled Supersaturation Plays an Essential Role in Improving Bioavailability

Application of different methods to predict the lipophilicity parameter of danazol

Multicenter Phase 2 Study of Combination Therapy with Ruxolitinib and Danazol in Patients with Myelofibrosis

Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems

Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry

Gonadotropin-releasing hormone analogues for endometriosis

Danazol for heavy menstrual bleeding

An in Vitro Digestion Test That Reflects Rat Intestinal Conditions To Probe the Importance of Formulation Digestion vs First Pass Metabolism in Danazol Bioavailability from Lipid Based Formulations

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels

Microbial transformation of danazol with Cunninghamella blakesleeana and anti-cancer activity of danazol and its transformed products

Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity

Electro-Oxidative C-N Bond Formation through Azolation of Indole Derivatives: An Access to 3-Substituent-2-(Azol-1-yl)indoles

Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis

Suchergebnisse filtern